{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:01:31Z","timestamp":1777518091092,"version":"3.51.4"},"reference-count":40,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T00:00:00Z","timestamp":1547596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Department of Health, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["630483"],"award-info":[{"award-number":["630483"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Review"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction and Aims<\/jats:title><jats:p>Increasing treatment uptake among people who inject drugs (PWID) with chronic hepatitis C virus (HCV) infection is integral to eliminating viral hepatitis. This study explored the role of community\u2010based outreach in engaging and retaining Australian PWID in the testing component of the HCV care cascade.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design and Methods<\/jats:title><jats:p>Semi\u2010structured interviews were conducted with 28 PWID, including new initiates to injecting and those from culturally and linguistically diverse (CALD) backgrounds, who acquired HCV infection while enrolled in a community\u2010based prospective observational study of hepatitis C vaccine preparedness in Sydney. Participants were interviewed at diagnosis and 12 months later. Transcripts were thematically analysed using constant comparative techniques.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Community\u2010based outreach was effective in engaging newly infected participants in HCV monitoring and decision\u2010making about seeking interferon\u2010based treatment. Key factors in the acceptability of outreach were privacy and discretion, and opportunities to build trust with non\u2010judgmental staff. Retaining participants in the HCV cascade of care required more than a one\u2010off session of post\u2010test counselling. Ongoing discussions with staff enabled paced and tailored delivery of information about HCV prevention, testing and treatment. Increased understanding of the role of HCV ribonucleic acid viremia in determining the need for treatment, and access to this testing, was pivotal in making HCV monitoring salient for participants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion and Conclusions<\/jats:title><jats:p>Outreach is an effective strategy for engaging new initiates to injecting and CALD PWID in HCV testing and decision\u2010making about treatment. Findings highlight the need to increase availability and access to HCV ribonucleic acid testing for PWID.<\/jats:p><\/jats:sec>","DOI":"10.1111\/dar.12895","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T02:45:31Z","timestamp":1547693131000},"page":"177-184","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Engaging people who inject drugs in hepatitis C virus testing and prevention through community\u2010based outreach, in Sydney, Australia"],"prefix":"10.1111","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2969-271X","authenticated-orcid":false,"given":"Heidi","family":"Coupland","sequence":"first","affiliation":[{"name":"The Kirby Institute, Faculty of Medicine UNSW Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bethany","family":"White","sequence":"additional","affiliation":[{"name":"The Kirby Institute, Faculty of Medicine UNSW Sydney  Sydney Australia"},{"name":"Central Clinical School University of Sydney and Drug Health Services, Sydney Local Health District  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Bates","sequence":"additional","affiliation":[{"name":"The Kirby Institute, Faculty of Medicine UNSW Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Nyeong","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health John Hopkins University  Baltimore USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Iversen","sequence":"additional","affiliation":[{"name":"The Kirby Institute, Faculty of Medicine UNSW Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Maher","sequence":"additional","affiliation":[{"name":"The Kirby Institute, Faculty of Medicine UNSW Sydney  Sydney Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,1,16]]},"reference":[{"key":"e_1_2_7_2_1","volume-title":"Global health sector strategy on viral hepatitis 2016\u20132021","author":"World Health Organization","year":"2016"},{"key":"e_1_2_7_3_1","volume-title":"General statement for drugs for the treatment of hepatitis C","author":"Australian Government Department of Health","year":"2017"},{"key":"e_1_2_7_4_1","volume-title":"Australian needle and syringe program survey national data report 2012\u20132016: prevalence of HIV, HCV and injecting and sexual behaviour among NSP attendees","author":"Memedovic S","year":"2017"},{"key":"e_1_2_7_5_1","unstructured":"IversenJ GrebelyJ CatlettB CunninghamP DoreG MaherL. Progress towards elimination: Factors associated with a ten\u2010fold increase in people who inject drugs initiating direct acting antiviral therapies in Australia in2016. World Hepatitis Summit; Sao Paulo Brazil2017."},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.05.022"},{"key":"e_1_2_7_7_1","first-page":"141","volume-title":"Drugs and public health Australian perspectives on policy and practice","author":"Maher L","year":"2008"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1071\/HE09234"},{"key":"e_1_2_7_9_1","first-page":"19","article-title":"Outtreach\u2010based HIV prevention for injecting drug users: a review of outcome studies","volume":"113","author":"Coyle S","year":"1998","journal-title":"Public Health Rep"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2004.009423"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01543.x"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.07.091"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2009.04.004"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2007.04.002"},{"key":"e_1_2_7_15_1","volume-title":"Ethical considerations in HIV biomedical prevention trials","author":"UNAIDS","year":"2012"},{"key":"e_1_2_7_16_1","unstructured":"National Health and Medical Research Council. National statement on ethical conduct in human research. Attorney General's department 2007."},{"key":"e_1_2_7_17_1","first-page":"239","article-title":"Ethical issues in HIV prevention research with people who inject drugs","volume":"11","author":"Sugarman J","year":"2014","journal-title":"Clin Infect Dis"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.09.019"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.10.009"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit300"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.05.027"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.11.049"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2010.05.001"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir196"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-6405.2012.00881.x"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.2307\/800824"},{"key":"e_1_2_7_27_1","volume-title":"Hepatitis C seroconversion. Using qualitative research to enhance surveillance","author":"Deacon R","year":"2009"},{"key":"e_1_2_7_28_1","first-page":"589","article-title":"A diagnosis of hepatitis C. Insight from a study of patients' experiences","volume":"39","author":"Treloar C","year":"2010","journal-title":"Aust Fam Physician"},{"key":"e_1_2_7_29_1","volume-title":"Experiences of HIV seroconversion. Final report 2007\u20102015","author":"Gianacas C","year":"2015"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13314"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dys167"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1086\/605947"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22534"},{"key":"e_1_2_7_34_1","first-page":"456","article-title":"Mechanisms through which drug, sex partner and friendship network characterstics relate to risky needle use among high risk youth and young adults","volume":"56","author":"Lakon C","year":"2006","journal-title":"Soc Sci Med"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.07.002"},{"key":"e_1_2_7_36_1","doi-asserted-by":"crossref","unstructured":"BajisS MaherL TreloarC et al. Acceptability and preferences of point\u2010of\u2010care finger\u2010stick whole\u2010blood and venepunture hepatitis C virus testing among people who inject drugs in Australia. Int J Drug Policy 2018;61:23\u201330.","DOI":"10.1016\/j.drugpo.2018.08.011"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2014-205224"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit938"},{"key":"e_1_2_7_39_1","volume-title":"Fourth National Hepatitis C Strategy 2014\u20132017","author":"Department of Health","year":"2014"},{"key":"e_1_2_7_40_1","first-page":"1","article-title":"Qualitative research and implementation science: informing the acceptability and implementation of a trial of a conditional cash transfer intervention designed to reduce drug use and HIV risk","volume":"9","author":"Dixon T","year":"2016","journal-title":"Methodol Innov"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2015.11.031"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdar.12895","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dar.12895","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T12:34:27Z","timestamp":1694694867000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dar.12895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,16]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1111\/dar.12895"],"URL":"https:\/\/doi.org\/10.1111\/dar.12895","archive":["Portico"],"relation":{},"ISSN":["0959-5236","1465-3362"],"issn-type":[{"value":"0959-5236","type":"print"},{"value":"1465-3362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,16]]},"assertion":[{"value":"2017-10-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}